Clin2
NCT07332143Possibly a fitNot yet recruiting

Psilocybin therapy for PTSD in Georgia veterans

PTSD

Treatments studied

Part of Mental health clinical trials.

This trial tests whether a drug called psilocybin, combined with therapy, can help treat PTSD. It is for Georgia military members and veterans who have had PTSD for at least 6 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are a Georgia military veteran, reservist, National Guard member, or active-duty service member.
  • You have PTSD from a traumatic event that happened at least 6 months ago.
  • You can read and understand English, swallow pills, and agree to have study visits recorded.
  • You have a support person (like a family member or friend) who can be contacted in an emergency.
  • If you can become pregnant, you must use highly effective birth control and have negative pregnancy tests.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05746572Enrolling by invitation· Phase 2
MDMA-assisted therapy plus exposure therapy for PTSD

This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.

Atlanta, Georgia
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06386003Recruiting· Phase 2
Psilocybin and talk therapy for chronic PTSD

This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.

Toronto, Ontario
NCT06902974Recruiting· Phase 2
Psilocybin therapy for PTSD from sexual assault

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Rockville, Maryland
NCT07704762Not yet recruiting· Phase 2
MDMA-assisted therapy for PTSD in military members

This trial tests if MDMA (a drug that can help with therapy) along with talk therapy can help military members with PTSD. It is designed for active duty, National Guard, or Reserve service members who have had PTSD for at least six months.

Hear when a new PTSD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.